US approves less-invasive heart defibrillator

(AP)—The U.S. Food and Drug Administration says it has approved a first-of-a-kind heart-zapping implant from Boston Scientific that that does not directly touch the heart.

Implantable defibrillators use thin wires to send that disrupt dangerous . Surgeons have traditionally connected the wires to the heart through a blood vessel in the upper chest.

The new device from Boston Scientific uses wires that sit just below the skin's surface and do not need to be threaded through the heart's blood vessels.

Boston Scientific Corp. acquired the device through a $150 million buyout of Cameron Health. Under the terms of the deal, Boston Scientific will pay an additional $150 million for FDA approval, plus up to $1 billion in payments based on future sales figures.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA wants stricter testing for defibrillators

Jan 21, 2011

(AP) -- The Food and Drug Administration is recommending stricter safety measures for heart-zapping defibrillators after years of increasing problems with the emergency medical devices.

Music headphones can interfere with heart devices

Nov 09, 2008

Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research presented at the American Heart Association's Scientific ...

Recommended for you

More variation in costs than outcomes of PCI in VA system

Jan 23, 2015

(HealthDay)—For patients undergoing percutaneous coronary intervention (PCI) in the Veterans Affairs (VA) system, the variation in one-year risk-adjusted mortality is smaller than variation in risk-standardized ...

Revolutionary device found to lower blood pressure

Jan 22, 2015

A revolutionary device has been shown to significantly lower blood pressure among patients with uncontrolled high blood pressure, compared to those treated with usual drug measures - according to research from Queen Mary ...

Metabolic syndrome may raise death risk postangiography

Jan 22, 2015

(HealthDay)—For postangiography patients, metabolic syndrome is associated with increased mortality, especially in patients with stable angina, according to a study published in the Feb. 1 issue of The Am ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.